MAL17055004AZPrescription (MAL-A)

Lamimac 150 (Lamivudine Tablets 150mg)

Generic Molecule: Lamivudine

ACTIVE & APPROVEDValid till: 3 May 2027
NPRA Official Regulatory Summary

Lamimac 150 (Lamivudine Tablets 150mg) is a KKM-approved Prescription Medicine registered under MAL number MAL17055004AZ by Paxten Sdn Bhd. Its active ingredient is LAMIVUDINE 150mg 310mg, manufactured by Macleods Pharmaceuticals Ltd..

Holder (PRH)
Paxten Sdn Bhd
Manufacturer
Macleods Pharmaceuticals Ltd.
First Registered
3 May 2022
Validity
3 May 2027

Prescription Required (Schedule Poison)

Need a valid doctor's prescription renewal in Malaysia?

Consult Online Doctor (Telehealth)

Active Ingredients & Strength Formulation

1 Component
Active Substance / MoleculeDeclared Strength / DosageGeneric Directory
LAMIVUDINE150mg 310mgFind Brands
Dosage values indicate declared active concentration per unit dose as registered with NPRA Malaysia.

Malaysian KKM Security Hologram Verification

FarmaChecker & Meditag™

By Malaysian Ministry of Health (KKM) regulation, all genuine registered pharmaceuticals, health supplements (MAL-N), and traditional products (MAL-T) distributed in Malaysia must feature an official tamper-evident security hologram sticker on the physical packaging.

1. Visual Tilt Check

Tilt the box under light to view the micro-engraved KKM coat of arms and multi-layer iridescent security patterns.

2. Match MAL Number

Ensure the printed MAL code matches MAL17055004AZ exactly on label and box.

3. FarmaChecker Scan

Scan using the official FarmaChecker app on iOS / Android to authenticate serial token with NPRA servers.

If the packaging lacks a security hologram or fails the FarmaChecker scan, do not consume and report to Cawangan Penguatkuasaan Farmasi (CPF KKM).
Frequently Asked Questions & Verification Details

Is Lamimac 150 (Lamivudine Tablets 150mg) approved by KKM / NPRA?

Yes. Lamimac 150 (Lamivudine Tablets 150mg) is actively registered with the National Pharmaceutical Regulatory Agency under official registration number MAL17055004AZ with current status PRODUCT APPROVED. Registration was filed by Paxten Sdn Bhd.

What are the active ingredients of Lamimac 150 (Lamivudine Tablets 150mg)?

The declared active therapeutic components are: LAMIVUDINE 150mg 310mg. Always follow dosage recommendations prescribed by a certified doctor or licensed pharmacist.

What are the registered generic alternatives in Malaysia?

In Malaysia, there are 19 registered brand formulations containing identical active ingredients (Lamivudine). You can review them in the alternative brands section above or consult your community pharmacist for generic bioequivalent substitution.

Semakan status pendaftaran KKM / NPRA: Lamimac 150 (Lamivudine Tablets 150mg) (MAL17055004AZ) | Pengganti ubat di Malaysia | Bahan aktif ubat & maklumat farmasi.